Research News and Research

RSS

Mylan first-quarter total revenues increase 7% to $1.29 billion

Mylan Inc. today announced its financial results for the three months ended March 31, 2010.

30 Apr 2010

Financial Times reports on challenges NGOs, development agencies face when partnering with businesses

The Financial Times reports on some of the challenges non-governmental organizations and development agencies face as they grow more accustomed to partnerships with businesses.

30 Apr 2010

$EnzymeRx reports positive results from first clinical trial of pegsitacase for refractory gout$

EnzymeRx reports positive results from first clinical trial of pegsitacase for refractory gout

EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.

30 Apr 2010

Women with family history of breast cancer face increase risk of ovarian cancer

Ovarian cancer is the most deadly disease of the female reproductive system, with most cases diagnosed in later stages. Yet while ovarian cancer affects 1 in 70 women in the United States, many women have never discussed the risk with their doctor.

30 Apr 2010

IPS examines how Uganda's anti-counterfeit bill could impact access to generic drugs

Inter Press Service examines Uganda's "controversial Counterfeit Goods Bill," which some say will limit the public's access to "life-saving generic medicines."

30 Apr 2010

Seniors often don't choose best quality Medicare Advantage plans, study finds

The Associated Press: "Millions of seniors signed up for popular Medicare Advantage insurance plans don't get the best quality, an independent study found. How the private plans score on a quality rating system set up by the government is about to have a direct impact on insurers' finances — not to mention seniors' benefits and premiums.

30 Apr 2010

Immunogen reports a net loss of $12.1 million in third quarter 2010

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced financial results for the three-month period ended March 31, 2010 - the third quarter of the Company's 2010 fiscal year (3QFY10).

30 Apr 2010

Tel Aviv scientist uncovers a new way of detecting multiple sclerosis

Multiple sclerosis (MS) is an equal opportunity destroyer. It attacks the central nervous system and eventually renders most patients disabled. Among its high-profile victims are celebrated cellist Jacqueline du Pre, whose career was ended by MS, and Joan Didion, one of America's greatest writers - but they are far from alone.

30 Apr 2010

West Pharmaceutical Services reports 13.3% increase in first-quarter consolidated sales

West Pharmaceutical Services, Inc. today announced its results for the first quarter of 2010.

30 Apr 2010

UC Irvine scientists receive CIRM grants for stem cell research

Two UC Irvine scientists will receive grants totaling more than $2.6 million to study the underlying biology of stem cells aimed at treating spinal cord injury, cancer and other disorders.

30 Apr 2010

Health insurers adopt reform changes early; WellPoint reports rising profits

Following announcements by leading health insurers that their firms would end the practice of rescission, or stripping the sick from their roles, the broader insurance industry followed suit, according to a letter from America's Health Insurance Plans to congressional Democrats, Politico reports. "The decision to end rescission … was made during a Tuesday afternoon conference call of chief executives organized by their trade group, America's Health Insurance Plans, and represents the industry's latest attempt to build political good will after the bruising health care fight."

30 Apr 2010

SickKids receives $8.9M grant for autism research

A research team co-led by Dr. Stephen Scherer, Senior Scientist at The Hospital for Sick Children (SickKids) was awarded an $8.9 million grant today from the Global Leadership Round in Genomics & Life Sciences (GL(2)), which is part of the Ontario Research Fund (ORF) by the Ministry of Research and Innovation (MRI).

30 Apr 2010

IRIC launches new RNA engineering laboratory in Canada

The Institute for Research in Immunology and Cancer of the Universit- de Montr-al is proud to announce the launch of the very first ribonucleic acid engineering laboratory in Canada.

30 Apr 2010

WellTek reports 115% increase in gross profit for fiscal year 2009

WellTek Incorporated, a global health, fitness and wellness company, is pleased to announce that the Company reported $2.54 million in revenue for the 2009 fiscal year ended December 31, 2009, representing a 15% increase over $2.20 million in revenue posted for 2008. The increase is primarily attributable to international sales by the Company's subsidiary, MedX Limited.

30 Apr 2010

States crack down on discount health plans

Kaiser Health News: "State regulators are cracking down on a health care product that targets the growing group of uninsured and underinsured Americans: the discount health plan.

30 Apr 2010

Consumer confusion triggers crackdown by states on discount health plans

Reporting for Kaiser Health News, Maggie Mertens writes: "State regulators are cracking down on a health care product that targets the growing group of uninsured and underinsured Americans: the discount health plan" (Mertens, 4/29).

30 Apr 2010

Clarient reports 14.8% increase in first quarter 2010 revenue

Clarient, Inc., a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today reported financial results for the first quarter ended March 31, 2010.

30 Apr 2010

Provenge cellular immunotherapy for men with advanced prostate cancer receives FDA approval

The U.S. Food and Drug Administration today approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.

30 Apr 2010

The closing of St. Vincent's Hospital creates many uncertainties in N.Y.

The Wall Street Journal reports on the closing of St. Vincent's Hospital in Manhattan. One story details how the staff of St. Vincent's has not yet received details about the hospital's closing on Friday. The hospital has been slowly winding down services since it announced its closure. "The emergency room stopped admitting patients and ambulances started going elsewhere, leaving the emergency room focused on walk-ins. Their needs have run the gamut. Tuesday night, for example, brought a patient with a possible ruptured aorta...

30 Apr 2010

Study promises a new treatment for cancer

Cancer cells producing toxins that destroy tumours - could this be a future treatment for cancer? Researchers at Lund University have achieved good results in tests on both cells and animals.

30 Apr 2010